2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines

World Allergy Organization Journal

Aziz Sheikh⁸  Hae-Sim Park⁹  Simon GA Brown⁷  Yehia M. El-Gamal^1,10  Richard F. Lockey²  Luciana Kase Tanno^1,11  Margitta Worm³  Bernard Y. Thong⁶  Mario Sanchez-Borges⁴  Motohiro Ebisawa¹  F. Estelle R. Simons⁵ 

[1] Department of Allergy, Clinical Research Center for Allergy & Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan;University of South Florida College of Medicine, Tampa, FL, USA;Allergie-Centrum-Charite, Klinik fur Dermatologie, Venerologie und Allergologie, Campus Charite Mitte, Universitatsmedizin, Berlin, Germany;Allergy and Clinical Immunology Department, Centro Medico-Docente La Trinidad, Caracas, Venezuela;Department of Pediatrics & Child Health and Department of Immunology, College of Medicine, Faculty of Health Sciences, The University of Manitoba, Room FE125, 820 Sherbrook Street, Winnipeg R3A 1R9, MB, Canada;Department of Rheumatology, Allergy & Immunology, Tan Tock Seng Hospital, Singapore, Singapore;Royal Hobart Hospital, Tasmania, and University of Western Australia and Royal Perth Hospital, Perth, Western Australia;Allergy & Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK;Department of Allergy & Clinical Immunology, Ajou University School of Medicine, Seoul, South Korea;Pediatric Allergy and Immunology Unit, Children’s Hospital, Ain Shams University, Cairo, Egypt;Department of Allergy and Clinical Immunology, Hospital Servidor Publico Estadual de Sao Paulo and Hospital Sirio-Libanes, Sao Paulo, Brazil

关键词: Adrenaline;    Systemic allergic reaction;    Exercise-induced anaphylaxis;    Latex allergy;    Drug allergy;    Stinging insect venom allergy;    Food allergy;    Auto-injector;    Epinephrine;    Anaphylaxis;   

Others  :  1234609
DOI  :  10.1186/s40413-015-0080-1

 received in 2015-08-06, accepted in 2015-09-25,  发布年份 2015

【 摘 要 】

The World Allergy Organization (WAO) Guidelines for the assessment and management of anaphylaxis provide a unique global perspective on this increasingly common, potentially life-threatening disease. Recommendations made in the original WAO Anaphylaxis Guidelines remain clinically valid and relevant, and are a widely accessed and frequently cited resource. In this 2015 update of the evidence supporting recommendations in the Guidelines, new information based on anaphylaxis publications from January 2014 through mid- 2015 is summarized. Advances in epidemiology, diagnosis, and management in healthcare and community settings are highlighted. Additionally, new information about patient factors that increase the risk of severe and/or fatal anaphylaxis and patient co-factors that amplify anaphylactic episodes is presented and new information about anaphylaxis triggers and confirmation of triggers to facilitate specific trigger avoidance and immunomodulation is reviewed. The update includes tables summarizing important advances in anaphylaxis research.

【 授权许可】

   
2015 Simons et al.

【 参考文献 】

• [1]Simons FER, Ardusso LRF, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. for the World Allergy Organization. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol. 2011;127:587–93. e1-e22.
• [2]Simons FER, Ardusso LRF, Bilo MB, Dimov V, Ebisawa M, El-Gamal YM et al.. for the World Allergy Organization. 2012 Update: World Allergy Organization (WAO) guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012; 12:389-99.
• [3]Simons FER, Ardusso LRF, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF et al.. for the World Allergy Organization. World Allergy Organization anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013; 162:193-204.
• [4]Simons FER, Ardusso LRF, Bilo MB, Cardona V, Ebisawa M, El-Gamal YM et al.. International consensus on (ICON) anaphylaxis. WAO J. 2014; 7:9.
• [5]Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M et al.. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014; 69:1026-45.
• [6]Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, et al. Anaphylaxis – a practice parameter update 2015. Ann Allergy Asthma Immunol. (in press).
• [7]Tejedor Alonso MA, Moro Moro M, Múgica García MV. Epidemiology of anaphylaxis. Clin Exp Allergy. 2015; 45:1027-39.
• [8]Wood RA, Camargo CA, Lieberman P, Sampson HA, Schwartz LB, Zitt M et al.. Anaphylaxis in America: The prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014; 133:461-7.
• [9]Rudders SA, Arias SA, Camargo CA. Trends in hospitalizations for food-induced anaphylaxis in US children, 2000–2009. J Allergy Clin Immunol. 2014; 134:960-2.
• [10]Nocerino R, Leone L, Cosenza L, Canani RB. Increasing rate of hospitalizations for food-induced anaphylaxis in Italian children: an analysis of the Italian Ministry of Health database. J Allergy Clin Immunol. 2015; 135:833-35.
• [11]Mullins RJ, Dear KBG, Tang MLK. Time trends in Australian hospital anaphylaxis admissions in 1998–1999 to 2011–2012. J Allergy Clin Immunol. 2015; 136:367-375.
• [12]Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T et al.. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015; 135:956-63.
• [13]Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014; 133:1075-83.
• [14]Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999–2010: Temporal patterns and demographic associations. J Allergy Clin Immunol. 2014; 134:1318-28.
• [15]Tanno LK, Calderon MA, Goldberg BJ, Akdis CA, Papadopoulos NG, Demoly P. Categorization of allergic disorders in the new World Health Organization International Classification of Diseases. Clin Transl. Allergy. 2014; 4:42.
• [16]Tanno LK, Calderon MA, Goldberg BJ, Gayraud J, Bircher AJ, Casale T et al.. Constructing a classification of hypersensitivity/allergic diseases for ICD-11 by crowdsourcing the allergist community. Allergy. 2015; 70:609-15.
• [17]Clark S, Wei W, Rudders SA, Camargo CA. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol. 2014; 134:1125-30.
• [18]Ye YM, Kim MK, Kang HR, Kim TB, Sohn SW, Koh YI, et al. for the KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis. Predictors of the severity and serious outcomes of anaphylaxis in Korean adults: a multicenter retrospective case study. Allergy Asthma Immunol Res. 2015;7:22–9.
• [19]Simons FER, Sampson HA. Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol. 2015; 135:1125-31.
• [20]Vazquez-Ortiz M, Alvaro M, Piquer M, Giner MT, Dominguez O, Lozano J et al.. Life-threatening anaphylaxis to egg and milk oral immunotherapy in asthmatic teenagers. Ann Allergy Asthma Immunol. 2014; 113:482-4.
• [21]Rutkowski K, Nasser SM. Management of hypersensitivity reactions to anti-D immunoglobulin preparations. Allergy. 2014; 69:1560-3.
• [22]Triggiani M, Montagni M, Parente R, Ridolo E. Anaphylaxis and cardiovascular diseases: a dangerous liaison. Curr Opin Allergy Clin Immunol. 2014; 14:309-15.
• [23]Lieberman P, Simons FER. Anaphylaxis and cardiovascular disease: therapeutic dilemmas. Clin Exp Allergy. 2015; 45:1288-95.
• [24]Rueff F, Vos B, Oude Elberink J, Bender A, Chatelain R, Dugas-Breit S et al.. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy. Clin Exp Allergy. 2014; 44:736-46.
• [25]Stoevesandt J, Hain J, Stolze I, Kerstan A, Trautmann A. Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase. Clin Exp Allergy. 2014; 44:747-55.
• [26]Nassiri M, Babina M, Dölle S, Edenharter G, Ruëff F, Worm M. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: Evidence for direct mast cell priming. J Allergy Clin Immunol. 2015; 135:491-9.
• [27]Valent P. Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders. Clin Exp Allergy. 2014; 44:914-20.
• [28]Gulen T, Hagglund H, Sander B, Dahlen B, Nilsson G. The presence of mast cell clonality in patients with unexplained anaphylaxis. Clin Exp Allergy. 2014; 44:1179-87.
• [29]Alvarez-Twose I, Zanotti R, Gonzalez-de-Olano D, Bonadonna P, Vega A, Matito A et al.. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM. J Allergy Clin Immunol. 2014; 133:520-8.
• [30]Broesby-Olsen S, Oropeza AR, Bindslev-Jensen C, Vestergaard H, Møller MB, Siebenhaar F et al.. Recognizing mastocytosis in patients with anaphylaxis: Value of KIT D816V mutation analysis of peripheral blood. J Allergy Clin Immunol. 2015; 135:262-4.
• [31]Fellinger C, Hemmer W, Wohrl S, Sesztak-Greinecker G, Jarisch R, Wantke F. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase. Allergol Immunopathol (Madr). 2014; 42:544-52.
• [32]Pravettoni V, Piantanida M, Primavesi L, Forti S, Pastorello EA. Basal platelet-activating factor acetylhydrolase: Prognostic marker of severe Hymenoptera venom anaphylaxis. J Allergy Clin Immunol. 2014; 133:1218-20.
• [33]Lyons JJ, Sun G, Stone KD, Nelson C, Wisch L, O’Brien M et al.. Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities. J Allergy Clin Immunol. 2014; 133:1471-4.
• [34]Fischer J, Hebsaker J, Caponetto P, Platts-Mills TA, Biedermann T. Galactose-alpha-1,3-galactose sensitization is a prerequisite for pork-kidney allergy and cofactor-related mammalian meat anaphylaxis. J Allergy Clin Immunol. 2014; 134:755-9.
• [35]Ansley L, Bonini M, Delgado L, Del Giacco S, Du Toit G, Khaitov M, et al. Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement. Allergy. 2015;70:1212-21.
• [36]Brockow K, Kneissl D, Valentini L, Zelger O, Grosber M, Kugler C et al.. Using a gluten oral food challenge protocol to improve diagnosis of wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol. 2015; 135:977-84.
• [37]Hox V, Desai A, Bandara G, Gilfillan AM, Metcalfe DD, Olivera A. Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production. J Allergy Clin Immunol. 2015; 135:729-36.
• [38]Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez-Rivas M, Cardona V et al.. First European data from the network of severe allergic reactions (NORA). Allergy. 2014; 69:1397-404.
• [39]Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014; 133:291-307.
• [40]Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D et al.. Food allergy: a practice parameter update - 2014. J Allergy Clin Immunol. 2014; 134:1016-25.
• [41]Umasunthar T, Leonardi-Bee J, Turner PJ, Hodes M, Gore C, Warner JO, et al. Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy. 2015;45:1621-1636.
• [42]Kamdar TA, Peterson S, Lau CH, Saltoun CA, Gupta RS, Bryce PJ. Prevalence and characteristics of adult-onset food allergy. J Allergy Clin Immunol Pract. 2015; 3:114-5.
• [43]Vetander M, Ly DH, Hakansson N, Lilja G, Nilsson C, Ostblom E et al.. Recurrent reactions to food among children at paediatric emergency departments: epidemiology of allergic disease. Clin Exp Allergy. 2014; 44:113-20.
• [44]van der Valk JPM, Dubois AEJ, Gerth van Wijk R, Wichers HJ, de Jong NW. Systematic review on cashew nut allergy. Allergy. 2014; 69:692-8.
• [45]Commins SP, James HR, Stevens W, Pochan SL, Land MH, King C et al.. Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose. J Allergy Clin Immunol. 2014; 134:108-15.
• [46]Takahashi K, Taniguchi M, Fukutomi Y, Sekiya K, Watai K, Mitsui C et al.. Oral mite anaphylaxis caused by mite-contaminated okonomiyaki/pancake-mix in Japan: 8 case reports and a review of 28 reported cases. Allergol Int. 2014; 63:51-6.
• [47]Kelso JM. Potential food allergens in medications. J Allergy Clin Immunol. 2014; 133:1509-18.
• [48]Levy Y, Segal N, Nahum A, Marcus N, Garty BZ. Hypersensitivity to methylprednisolone sodium succinate in children with milk allergy. J Allergy Clin Immunol Pract. 2014; 2:471-4.
• [49]Hamilton RG, Scheer DI, Gruchalla R, Adkinson NF, Sampson HA. Casein-related anaphylaxis after use of an Everlast kickboxing glove. J Allergy Clin Immunol. 2015; 135:269-71.
• [50]Golden DB. New directions in diagnostic evaluation of insect allergy. Curr Opin Allergy Clin Immunol. 2014; 14:334-9.
• [51]Casale TB, Burks AW. Hymenoptera-sting hypersensitivity. N Engl J Med. 2014; 370:1432-9.
• [52]Sturm GJ, Kranzelbinder B, Schuster C, Sturm EM, Bokanovic D, Vollmann J et al.. Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare. J Allergy Clin Immunol. 2014; 133:1635-43.
• [53]Cifuentes L, Vosseler S, Blank S, Seismann H, Darsow U, Bredehorst R et al.. Identification of Hymenoptera venom-allergic patients with negative specific IgE to venom extract by using recombinant allergens. J Allergy Clin Immunol. 2014; 133:909-10.
• [54]Kohler J, Blank S, Muller S, Bantleon F, Frick M, Huss-Marp J et al.. Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol. 2014; 133:1383-9.
• [55]Banerji A, Rudders S, Clark S, Wei W, Long AA, Camargo CA. Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up. J Allergy Clin Immunol Pract. 2014; 2:46-51.
• [56]Jares EJ, Sánchez-Borges M, Cardona-Villa R, Ensina LF, Arias-Cruz A, Gómez M et al.. Multinational experience with hypersensitivity drug reactions in Latin America. Ann Allergy Asthma Immunol. 2014; 113:282-9.
• [57]Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International consensus on drug allergy. Allergy. 2014;69:420–37.
• [58]Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort study. J Allergy Clin Immunol. 2014; 133:790-6.
• [59]Li M, Krishna MT, Razaq S, Pillay D. A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of “penicillin allergy” in a UK teaching hospital. J Clin Pathol. 2014; 67:1088-92.
• [60]Fox SJ, Park MA. Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population. J Allergy Clin Immunol Pract. 2014; 2:439-44.
• [61]Macy E, Contreras R. Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis. J Allergy Clin Immunol. 2015; 135:745-52.
• [62]Gaeta F, Valluzzi RL, Alonzi C, Maggioletti M, Caruso C, Romano A. Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol. 2015; 135:972-6.
• [63]Uyttebroek AP, Sabato V, Bridts CH, De Clerck LS, Ebo DG. Moxifloxacin hypersensitivity: uselessness of skin testing. J Allergy Clin Immunol Pract. 2015; 3:443-5.
• [64]Mori F, Pecorari L, Pantano S, Rossi ME, Pucci N, De Martino M et al.. Azithromycin anaphylaxis in children. Int J Immunopathol Pharmacol. 2014; 27:121-6.
• [65]Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA et al.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014; 2:414-20.
• [66]Faria E, Rodrigues-Cernadas J, Gaspar A, Botelho C, Castro E, Lopes A et al.. Drug-induced anaphylaxis survey in Portuguese allergy departments. J Investig Allergol Clin Immunol. 2014; 24:40-8.
• [67]Picaud J, Beaudouin E, Renaudin JM, Pirson F, Metz-Favre C, Dron-Gonzalvez M et al.. Anaphylaxis to diclofenac: nine cases reported to the Allergy Vigilance Network in France. Allergy. 2014; 69:1420-3.
• [68]Craig TJ, Li H, Riedl M, Bernstein JA, Lumry WR, MacGinnitie AJ et al.. Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2015; 3:206-12.
• [69]Galvao VR, Castells MC. Hypersensitivity to biological agents – updated diagnosis, management, and treatment. J Allergy Clin Immunol Pract. 2015; 3:175-85.
• [70]Savic LC, Kaura V, Yusaf M, Hammond-Jones AM, Jackson R, Howell S et al.. Incidence of suspected perioperative anaphylaxis: A multicenter snapshot study. J Allergy Clin ImmunolPract. 2015; 3:454-5.
• [71]Reitter M, Petitpain N, Latarche C, Cottin J, Massy N, Demoly P et al.. Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis. Allergy. 2014; 69:954-9.
• [72]Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia. 2014; 69:1251-7.
• [73]Opstrup MS, Malling HJ, Kroigaard M, Mosbech H, Skov PS, Poulsen LK et al.. Standardized testing with chlorhexidine in perioperative allergy – a large single-centre evaluation. Allergy. 2014; 69:1390-6.
• [74]Péer L, Brezis ML, Shalit M, Carvalho B, Levin PD, Seri O et al.. Evaluation of a prospectively administered written questionnaire to reduce the incidence of suspected latex anaphylaxis during elective cesarean delivery. Int J Obstet Anesth. 2014; 23:335-40.
• [75]Kim MH, Lee SY, Lee SE, Yang MS, Jung JW, Park CM et al.. Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock. PLoS One. 2014; 9:e100154.
• [76]Raisch DW, Garg V, Arabyat R, Shen X, Edwards BJ, Miller FH et al.. Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration’s adverse event reporting system and review of case reports in the literature. Expert Opin Drug Saf. 2014; 13:15-23.
• [77]Ha SO, Kim DY, Sohn CH, Lim KS. Anaphylaxis caused by intravenous fluorescein: clinical characteristics and review of literature. Intern Emerg Med. 2014; 9:325-30.
• [78]Campbell RL, Li JT, Nicklas RA, Sadosty AT. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014; 113:599-608.
• [79]Wang J, Young MC, Nowak-Węgrzyn A. International survey of knowledge of food-induced anaphylaxis. Pediatr Allergy Immunol. 2014; 25:644-50.
• [80]Sargant N, Erlewyn-Lajeunesse M, Benger J. Does anaphylaxis masquerade as asthma in children? Emerg Med J. 2015; 32:83-4.
• [81]Murali MR, Uyeda JW, Tingpej B. Case 2–2015: a 25-year-old man with abdominal pain, syncope, and hypotension. N Engl J Med. 2015; 372:265-73.
• [82]Hsu P, Xie Z, Frith K, Wong M, Kakakios A, Stone KD et al.. Idiopathic systemic capillary leak syndrome in children. Pediatrics. 2015; 135:e730-e735.
• [83]Sherenian MG, Clee M, Schondelmeyer AC, de Alarcon A, Li J, Assa’ad A, et al. Caustic ingestions mimicking anaphylaxis: case studies and literature review. Pediatrics. 2015;135:e547–50.
• [84]Plumb B, Bright P, Gompels MM, Unsworth DJ. Correct recognition and management of anaphylaxis: not much change over a decade. Postgrad Med J. 2015; 91:3-7.
• [85]Wongkaewpothong P, Pacharn P, Sripramong C, Boonchoo S, Piboonpocanun S, Visitsunthorn N et al.. The utility of serum tryptase in the diagnosis of food-induced anaphylaxis. Allergy Asthma Immunol Res. 2014; 6:304-9.
• [86]Laroche D, Gomis P, Gallimidi E, Malinovsky JM, Mertes PM. Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anesthesia. Anesthesiology. 2014; 121:272-9.
• [87]Krishna MT, York M, Chin T, Gnanakumaran G, Heslegrave J, Derbridge C et al.. Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase. Clin Exp Immunol. 2014; 178:399-404.
• [88]McLean-Tooke A, Goulding M, Bundell C, White J, Hollingsworth P. Post-mortem serum tryptase levels in anaphylactic and non-anaphylactic deaths. J Clin Pathol. 2014; 67:134-8.
• [89]Sala-Cunill A, Bjorkqvist J, Senter R, Guilarte M, Cardona V, Labrador M et al.. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. J Allergy Clin Immunol. 2015; 135:1031-43.
• [90]Stone SF, Bosco A, Jones A, Cotterell CL, van Eeden PE, Arendts G et al.. Genomic responses during acute human anaphylaxis are characterized by upregulation of innate inflammatory gene networks. PLoS One. 2014; 9:e101409.
• [91]Dhami S, Panesar SS, Roberts G, Muraro A, Worm M, Bilò MB et al.. Management of anaphylaxis: a systematic review. Allergy. 2014; 69:168-75.
• [92]Fleming JT, Clark S, Camargo CA, Rudders SA. Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract. 2015; 3:57-62.
• [93]Xu YS, Kastner M, Harada L, Xu A, Salter J, Waserman S. Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011. Allergy Asthma Clin Immunol. 2014; 10:38.
• [94]Hitti EA, Zaitoun F, Harmouche E, Saliba M, Mufarrij A. Acute allergic reactions in the emergency department: characteristics and management practices. Eur J Emerg Med. 2015; 22:253-9.
• [95]Manivannan V, Hess EP, Bellamkonda VR, Nestler DM, Bellolio MF, Hagan JB, et al. A multifaceted intervention for patients with anaphylaxis increases epinephrine use in adult emergency department. J Allergy Clin Immunol Pract. 2014;2:294–9. e1.
• [96]Asai Y, Yanishevsky Y, Clarke A, La Vieille S, Delaney JS, Alizadehfar R et al.. Rate, triggers, severity and management of anaphylaxis in adults treated in a Canadian emergency department. Int Arch Allergy Immunol. 2014; 164:246-52.
• [97]Chung T, Gaudet L, Vandenberghe C, Couperthwaite S, Sookram S, Liss K et al.. Pre-hospital management of anaphylaxis in one Canadian urban centre. Resuscitation. 2014; 85:1077-82.
• [98]Manivannan V, Hyde RJ, Hankins DG, Bellolio MF, Fedko MG, Decker WW et al.. Epinephrine use and outcomes in anaphylaxis patients transported by emergency medical services. Am J Emerg Med. 2014; 32:1097-1102.
• [99]Campbell RL, Bellolio MF, Knutson BD, Bellamkonda VR, Fedko MG, Nestler DM, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015;3:76–80.
• [100]Nurmatov UB, Rhatigan E, Simons FER, Sheikh A. H 2 -antihistamines for the treatment of anaphylaxis with and without shock: a systematic review. Ann Allergy Asthma Immunol. 2014; 112:126-31.
• [101]Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2015; 3:408-16.
• [102]Lo JCY, Darracq MA, Clark RF. A review of methylene blue treatment for cardiovascular collapse. J Emerg Med. 2014; 46:670-9.
• [103]Zhang Z, Su X, Liu C. Cardiac arrest with anaphylactic shock: a successful resuscitation using extracorporeal membrane oxygenation. Am J Emerg Med. 2015;33:130.e3-4.
• [104]Campbell RL, Park MA, Kueber MA, Lee S, Hagan JB. Outcomes of allergy/immunology follow-up after an emergency department evaluation for anaphylaxis. J Allergy Clin Immunol Pract. 2015; 3:88-93.
• [105]Altman AM, Camargo CA, Simons FER, Lieberman P, Sampson HA, Schwartz LB et al.. Anaphylaxis in America: a national physician survey. J Allergy Clin Immunol. 2015; 135:830-3.
• [106]Bonds RS, Asawa A, Ghazi AI. Misuse of medical devices: a persistent problem in self-management of asthma and allergic disease. Ann Allergy Asthma Immunol. 2015; 114:74-6.
• [107]Edwards ES, Edwards ET, Simons FER, North R. Drug-device combination products in the 21 st century: development using a human factors engineering approach. Expert Opin Drug Deliv. 2015; 12:751-62.
• [108]Umasunthar T, Procktor A, Hodes M, Smith JG, Gore C, Cox HE et al.. Patients’ ability to treat anaphylaxis using adrenaline auto-injectors: a randomized controlled trial. Allergy. 2015; 70:855-63.
• [109]Rachid O, Simons FER, Wein MB, Rawas-Qalaji M, Simons KJ. Epinephrine doses contained in outdated epinephrine auto-injectors collected in a Florida allergy practice. Ann Allergy Asthma Immunol. 2015; 114:354-6.
• [110]Rachid O, Simons FER, Rawas-Qalaji M, Lewis S, Simons KJ. Epinephrine autoinjectors: does freezing or refrigeration affect epinephrine dose delivery and enantiomeric purity? J Allergy Clin Immunol Pract. 2015; 3:294-6.
• [111]Topal E, Bakirtas A, Yilmaz O, Karagol IHE, Arga M, Demirsoy MS et al.. When should we perform a repeat training on adrenaline auto-injector use for physician trainees? Allergol Immunopathol (Madr). 2014; 42:472-5.
• [112]Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N et al.. including the working group on anaphylaxis training education (AGATE). Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy. 2015; 70:227-35.
• [113]Salter SM, Vale S, Sanfilippo FM, Loh R, Clifford RM. Long-term effectiveness of online anaphylaxis education for pharmacists. Am J Pharm Educ. 2014; 78:136.
• [114]Zadikoff EH, Whyte SA, DeSantiago-Cardenas L, Harvey-Gintoft B, Gupta RS. The development and implementation of the Chicago public schools emergency EpiPen policy. J Sch Health. 2014; 84:342-7.
• [115]Mok G, Vaillancourt R, Irwin D, Wong A, Zemek R, Alqurashi W. Design and validation of pictograms in a pediatric anaphylaxis action plan. Pediatr Allergy Immunol. 2015; 26:223-33.
• [116]Wahl A, Stephens H, Ruffo M, Jones AL. The evaluation of a food allergy and epinephrine autoinjector training program for personnel who care for children in schools and community settings. J Sch Nurs. 2015; 31:91-8.
• [117]Le TM, Kummeling I, Dixon D, Tolosa LB, Ballmer-Weber B, Clausen M et al.. Low preparedness for food allergy as perceived by school staff: a EuroPrevall survey across Europe. J Allergy Clin Immunol Pract. 2014; 2:480-2.
• [118]Muraro A, Agache I, Clark A, Sheikh A, Roberts G, Akdis CA et al.. EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community. Allergy. 2014; 69:1046-57.
• [119]Bird JA, Lack G, Perry TT. Clinical management of food allergy. J Allergy Clin Immunol Pract. 2015; 3:1-11.
• [120]Gupta RS, Lau CH, Hamilton RG, Donnell A, Newhall KK. Predicting outcomes of oral food challenges by using the allergen-specific IgE—total IgE ratio. J Allergy Clin Immunol Pract. 2014; 2:300-5.
• [121]Ebisawa M, Moverare R, Sato S, Borres MP, Ito K. The predictive relationship between peanut- and Ara h2-specific serum IgE concentrations and peanut allergy. J Allergy Clin Immunol Pract. 2015; 3:131-2.
• [122]Santos AF, Douiri A, Bécares N, Wu SY, Stephens A, Radulovic S et al.. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children. J Allergy Clin Immunol. 2014; 134:645-52.
• [123]Turner PJ, Kumar K, Fox AT. Skin testing with raw egg does not predict tolerance to baked egg in egg-allergic children. Pediatr Allergy Immunol. 2015; 25:657-61.
• [124]Leonard SA, Caubet JC, Kim JS, Groetch M, Nowak-Wegrzyn A. Baked milk- and egg-containing diet in the management of milk and egg allergy. J Allergy Clin Immunol Pract. 2015; 3:13-23.
• [125]Mehr S, Turner PJ, Joshi P, Wong M, Campbell DE. Safety and clinical predictors of reacting to extensively heated cow’s milk challenge in cow’s milk-allergic children. Ann Allergy Asthma Immunol. 2014; 113:425-9.
• [126]Lee E, Mehr S, Turner PJ, Joshi P, Campbell DE. Adherence to extensively heated egg and cow’s milk after successful oral food challenge. J Allergy Clin Immunol Pract. 2015; 3:125-7.
• [127]Franxman TJ, Howe L, Teich E, Greenhawt MJ. Oral food challenge and food allergy quality of life in caregivers of children with food allergy. J Allergy Clin Immunol Pract. 2015; 3:50-6.
• [128]Mehta H, Ramesh M, Feuille E, Groetch M, Wang J. Growth comparison in children with and without food allergies in 2 different demographic populations. J Pediatr. 2014; 165:842-8.
• [129]Protudjer JLP, Jansson SA, Arnlind MH, Bengtsson U, Kallstrom-Bengtsson I, Marklund B et al.. Household costs associated with objectively diagnosed allergy to staple foods in children and adolescents. J Allergy Clin Immunol Pract. 2015; 3:68-75.
• [130]Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP et al.. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014; 133:468-75.
• [131]Burks AW, Wood RA, Jones SM, Sicherer SH, Fleischer DM, Scurlock AM et al.. Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol. 2015; 135:1240-8.
• [132]Elizur A, Goldberg MR, Levy MB, Nachshon L, Katz Y. Oral immunotherapy in cow’s milk allergic patients: course and long-term outcome according to asthma status. Ann Allergy Asthma Immunol. 2015; 114:240-4.
• [133]Burton OT, Logsdon SL, Zhou JS, Medina-Tamayo J, Abdel-Gadir A, Rivas MN et al.. Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity. J Allergy Clin Immunol. 2014; 134:1310-7.
• [134]Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF et al.. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015; 372:803-13.
• [135]Muller UR, Ring J. When can immunotherapy for insect sting allergy be stopped? J Allergy Clin Immunol Pract. 2015; 3:324-8.
• [136]Palgan K, Bartuzi Z, Gotz-Zbikowska M. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting. Int J Immunopathol Pharmacol. 2014; 27:109-12.
• [137]Baker TW, Forester JP, Johnson ML, Stolfi A, Stahl MC. The HIT study: Hymenoptera Identification Test – how accurate are people at identifying stinging insects? Ann Allergy Asthma Immunol. 2014; 113:267-70.
• [138]Koschel DS, Schmies M, Weber CN, Hoffken G, Balck F. Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life. J Investig Allergol Clin Immunol. 2014; 24:226-30.
• [139]Mullins RJ, Brown SGA. Ant venom immunotherapy in Australia: the unmet need. Med J Aust. 2014; 201:33-4.
• [140]Syrigou E, Syrigos K. Anaphylaxis during skin prick testing for amoxicillin allergy. J Allergy Clin Immunol Pract. 2014; 2:478-9.
• [141]Park MA, Solensky R, Khan DA, Castells MC, Macy EM, Lang DM. Patients with positive skin test results to penicillin should not undergo penicillin or amoxicillin challenge. J Allergy Clin Immunol. 2015; 135:816-7.
• [142]Bourke J, Pavlos R, James I, Phillips E. Improving the effectiveness of penicillin allergy de-labeling. J Allergy Clin Immunol Pract. 2015; 3:365-74.
• [143]Pyle RC, Butterfield JH, Volcheck GW, Podjasek JC, Rank MA, Li JTC et al.. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction. J Allergy Clin Immunol Pract. 2014; 2:52-8.
• [144]Ensina LF, de Lacerda AE, de Andrade DM, Machado L, Camelo-Nunes I, Solé D. Drug-induced anaphylaxis in children: Nonsteroidal anti-inflammatory drugs and drug provocation test. J Allergy Clin Immunol Pract. 2014; 2:825.
• [145]Guyer AC, Saff RR, Conroy M, Blumenthal KG, Camargo CA, Long AA et al.. Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia. J Allergy Clin Immunol Pract. 2015; 3:94-100.
• [146]Oltean S, Epure A, Lindstrom K, Pardi C. Detection of anti-IgA antibodies using the particle gel immunoassay: a rapid test for increased patient safety. Blood Transfus. 2014; 12:334-9.
• [147]Hong DI, Dioun AF. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children. J Allergy Clin Immunol Pract. 2014; 2:13-9.
• [148]Kelso JM. Influenza vaccine and egg allergy: nearing the end of an evidence-based journey. J Allergy Clin Immunol Pract. 2015; 3:140-1.
• [149]Heaps A, Carter S, Selwood C, Moody M, Unsworth J, Deacock S et al.. The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis. Clin Exp Immunol. 2014; 177:483-90.
• [150]Borzutzky A, Morales PS, Mezzano V, Nussbaum S, Burks AW. Induction of remission of idiopathic anaphylaxis with rituximab. J Allergy Clin Immunol. 2014; 134:981-3.